Evon Poon

6PUBLICATIONS
97CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 24, 2026
Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

|Sep 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity.

Shivendra Singh, Jie Fang, Hongjian Jin

|May 03, 2024
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.

Ingrid M Saldana-Guerrero, Luis F Montano-Gutierrez, Katy Boswell

|Jan 05, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Elizabeth R Tucker, Irene Jiménez, Lindi Chen

|Mar 17, 2022
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.

Anke Nijhuis, Arti Sikka, Orli Yogev

|Sep 15, 2021
The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme.

Zuzanna Urban-Wójciuk, Amy Graham, Karen Barker

Pageof 1

Frequent Collaborators

5 joint publications

Louis Chesler

3 joint publications

Yann Jamin

2 joint publications

Karen T Barker

2 joint publications

Barbara Martins Da Costa